ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria’s Director Nominees Dec 8, 2025 08:01AM
Neuphoria rejects Lynx1's revised $4.75 acquisition offer Dec 4, 2025 08:02AM
Neuphoria counters Lynx1 claims in proxy fight defense Dec 1, 2025 08:01AM
Neuphoria urges shareholders to vote for company nominees amid proxy fight Nov 24, 2025 08:01AM
Neuphoria initiates strategic review after $5.20 buyout offer Nov 11, 2025 07:00AM


Oct 27, 2025 04:29PM Neuphoria Therapeutics adopts stockholder rights plan amid stock accumulation
Oct 21, 2025 06:08AM Lucid Capital Markets Downgrades Neuphoria Therapeutics Inc. (NEUP) to Neutral
Sep 29, 2025 04:55PM Neuphoria completes phase 3 trial milestone for anxiety drug BNC-210
Sep 10, 2025 12:55PM Neuphoria Therapeutics Inc. (NEUP) PT Raised to $35 at Maxim Group
Feb 12, 2025 07:02AM Neuphoria (NEUP) to Receive $15M Milestone Payment from Merck
Jan 7, 2025 06:21AM Neuphoria (NEUP) Files $100M Mixed Shelf